1 INTRODUCTION 1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET 1.2. MARKET SEGMENTATION & COVERAGE 1.2.1. CURRENCY AND PRICING 1.2.2. LIMITATION 1.2.3. STAKEHOLDERS 2 RESEARCH METHODOLOGY 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE 2.2.1. MARKET CRACKDOWN APPROACH 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3. DATA TRIANGULATION 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES 2.2.6. PORTER’S FIVE FORCES MATRIX 2.4. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT 2.5. ASSUMPTIONS 3 MARKET LANDSCAPE SUMMARY 4 PREMIUM INSIGHTS 4.1. OVERVIEW 4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS 4.3. MARKET OVERVIEW 4.3.1. DRIVERS 4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES 4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR 4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES 4.3.1.4. EXPANDED TARGET APPLICATIONS 4.3.2. RESTRAINTS 4.3.2.1. LACK OF PATIENT AWARENESS 4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS 4.3.3. OPPURTUNITIES 4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY 4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS 4.3.4. THREATS 4.3.4.1. DONOR SITE MORBIDITY 4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES 5 EXECUTIVE SUMMARY 6 NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE 6.1. OVERVIEW 6.2. NERVE REPAIR 6.2.1. NERVE CONDUITS 6.2.2. NERVE GRAFTS 6.2.2.1. ALLOGRAFTS 6.2.2.2. ACELLULARIZED ALLOGRAFTS 6.3. NERVE PROTECTION 6.3.1. NERVE PROTECTOR 6.3.2. NERVE WRAP 7 NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE 7.1. OVERVIEW 7.2. EPINEURAL NERVE REPAIR 7.3. PERINEURAL NERVE REPAIR 7.4. GROUP FASCICULAR NERVE REPAIR 8 NERVE REPAIR BIOMATERIALS MARKET, BY END USER 8.1. OVERVIEW 8.2. HOSPITALS 8.3. AMBULATORY TRAUMA CENTERS 8.4. CLINICS 9 NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY 9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) 9.1.1. NORTH AMERICA 9.1.1.1. U.S. 9.1.1.2. CANADA 9.1.1.3. MEXICO 9.1.2. EUROPE 9.1.2.1. GERMANY 9.1.2.2. FRANCE 9.1.2.3. U.K. 9.1.2.4. ITALY 9.1.2.5. SPAIN 9.1.2.6. RUSSIA 9.1.2.7. TURKEY 9.1.2.8. BELGIUM 9.1.2.9. NETHERLANDS 9.1.2.10. SWITZERLAND 9.1.2.11. REST OF EUROPE 9.1.3. ASIA-PACIFIC (APAC) 9.1.3.1. JAPAN 9.1.3.2. CHINA 9.1.3.3. SOUTH KOREA 9.1.3.4. INDIA 9.1.3.5. AUSTRALIA 9.1.3.6. SINGAPORE 9.1.3.7. THAILAND 9.1.3.8. MALAYSIA 9.1.3.9. INDONESIA 9.1.3.10. PHILIPPINES 9.1.3.11. REST OF APAC 9.1.4. LATIN AMERICA 9.1.4.1. BRAZIL 9.1.4.2. REST OF LATIN AMERICA 9.1.5. MIDDLE EAST AND AFRICA 9.1.5.1. SOUTH AFRICA 9.1.5.2. REST OF MIDDLE EAST AND AFRICA 9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES 10 NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE 10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS 10.7. MERGERS & ACQUISITIONS 10.8. NEW PRODUCT DEVELOPMENT & APPROVALS 10.10. EXPANSIONS 10.10. REGULATORY CHANGES 10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 11 NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES 11.1 AXOGEN, INC. 11.1.1 COMPANY OVERVIEW 11.1.2 SWOT ANALYSIS 11.1.3 REVENUE ANALYSIS 11.1.4 PRODUCT PORTFOLIO 11.1.5 RECENT DEVELOPEMENTS 11.1.5 DATA BRIDGE ANALYSIS 11.2 CHECKPOINT SURGICAL, INC. 11.2.1 COMPANY OVERVIEW 11.2.2 SWOT ANALYSIS 11.2.3 REVENUE ANALYSIS 11.2.4 PRODUCT PORTFOLIO 11.2.5 RECENT DEVELOPEMENTS 11.2.5 DATA BRIDGE ANALYSIS 11.3 COLLAGEN MATRIX, INC. 11.3.1 COMPANY OVERVIEW 11.3.2 SWOT ANALYSIS 11.3.3 REVENUE ANALYSIS 11.3.4 PRODUCT PORTFOLIO 11.3.5 RECENT DEVELOPEMENTS 11.3.5 DATA BRIDGE ANALYSIS 11.4 INTEGRA LIFESCIENCES CORPORATION 11.4.1 COMPANY OVERVIEW 11.4.2 SWOT ANALYSIS 11.4.3 REVENUE ANALYSIS 11.4.4 PRODUCT PORTFOLIO 11.4.5 RECENT DEVELOPEMENTS 11.4.5 DATA BRIDGE ANALYSIS 11.5 POLYGANICS B.V. 11.5.1 COMPANY OVERVIEW 11.5.2 SWOT ANALYSIS 11.5.3 REVENUE ANALYSIS 11.5.4 PRODUCT PORTFOLIO 11.5.5 RECENT DEVELOPEMENTS 11.5.5 DATA BRIDGE ANALYSIS 11.6 STRYKER CORPORATION 11.6.1 COMPANY OVERVIEW 11.6.2 SWOT ANALYSIS 11.6.3 REVENUE ANALYSIS 11.6.4 PRODUCT PORTFOLIO 11.6.5 RECENT DEVELOPEMENTS 11.6.5 DATA BRIDGE ANALYSIS 11.7 SYNOVIS MICRO COMPANIES ALLIANCE, INC. 11.7.1 COMPANY OVERVIEW 11.7.2 SWOT ANALYSIS 11.7.3 REVENUE ANALYSIS 11.7.4 PRODUCT PORTFOLIO 11.7.5 RECENT DEVELOPEMENTS 11.7.5 DATA BRIDGE ANALYSIS 12 APPENDIX 13 ABOUT DATA BRIDGE MARKET RESEARCH